Key Takeaways Eli Lilly's Zepbound can be covered by Medicare Part D plans after the FDA approved the drug as a treatment for ...
The government-funded insurance plan will now pay for the drug for patients with obstructive sleep apnea, a condition that ...
El Lilly’s blockbuster weight-loss drug Zepbound is now eligible for coverage under Medicare prescription drug plans, when ...
1hon MSN
There is a photo that exemplifies the paradox of Robert F. Kennedy Jr.’s nomination as secretary of the Health and Human ...
Political and economic uncertainty hangs over the industry, while major bets on metabolic and immune disease drug research are set to play out.
US intelligence finds no proof tying 'Havana syndrome' health issues to foreign actors, but 2 agencies say it's possible.
What dietary habits reduce inflammation? What snacks boost brain health? TODAY nutrition and health expert Joy Bauer stops by ...
Adam Maeder, an analyst from Piper Sandler, has initiated a new Hold rating on Resmed (RMD).Stay Ahead of the Market:Discover outperforming ...
Piper Sandler initiated coverage of ResMed (RMD) with a Neutral rating and $252 price target While there’s a lot to like about the ResMed ...
The cost of prescription drugs is set to climb in 2025 and beyond, according to TD Cowen’s 30th Annual Drug Pricing survey.
Themis Medicare Ltd., incorporated in the year 1969, is a Small Cap company (having a market cap of Rs 2,496.59 Crore) operating in Pharmaceuticals sector. Themis Medicare Ltd. key Products/Revenue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback